Aspen Spinous Process Fixation System for Use in PLF in Patients With Spondylolisthesis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

25 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-02-29

Study Completion Date

2015-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this clinical investigation is to evaluate the clinical outcomes of subject with spondylolisthesis undergoing posterolateral fusion (PLF) surgery utilizing the Aspen™ Spinous Process Fixation System. The Aspen™ device will be evaluated using Oswestry Disability Index (ODI) improvement and success of fusion.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of the Aspen Device Versus Pedicle Screws for Supplemental Posterior Fixation in Lumbar Interbody Fusion

NCT01549366

Degeneration of Lumbar Intervertebral Disc

COMPLETED NA

Efficacy of the Aspen Spinous Process System in Anterior Lumbar Interbody Fusion (ALIF)

NCT01016314

Degenerative Disc Disease

WITHDRAWN NA

Evaluation of Aspen Spinous Process Fixation System and PLIF Technique for the Treatment of Low Back Pain

NCT01918943

Low Back Pain Spondylolisthesis Spondylosis +2 more

UNKNOWN

Evaluation Of Spinelink® Fixation In The Treatment Of Degenerative Spondylolisthesis And Spinal Instability

NCT00726310

Degenerative Disc Disease Degenerative Spondylolisthesis

COMPLETED

Clinical Outcomes of the Trinica(R) Anterior Lumbar Plate: Fixed Screws vs. Variable Screws

NCT00762723

Degenerative Disc Disease Spinal Stenosis Spondylolisthesis

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Evaluate the clinical outcomes of subject with spondylolisthesis undergoing posterolateral fusion (PLF) surgery utilizing the Aspen™ Spinous Process Fixation System. The Aspen™ device will be evaluated using Oswestry Disability Index (ODI) improvement and success of fusion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spondylolisthesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aspen Spinous Process Fixation Device

The Aspen device provides supplemental posterior fixation for fusion

Aspen Spinous Process Fixation Device

Intervention Type DEVICE

The Aspen device will be placed as posterior fixation to Posterolateral Fusion (PLF)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Aspen Spinous Process Fixation Device

The Aspen device will be placed as posterior fixation to Posterolateral Fusion (PLF)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age between 50 and older
* Diagnosis of mild segmental instability on standing radiography lateral film defined as degenerative spondylolisthesis ≤ 4mm in dynamic imaging (i.e., flexion/extension)
* Scheduled for an elective single-level posterior decompression and posterolateral fusion using AspenTM spinous process fixation system
* Oswestry Disability Index (ODI) v 2.1 score \>30%
* Failed at least 3 months of conservative care (non-surgical) OR has clinical signs of neurological deterioration
* Signed Informed Consent Form

Exclusion Criteria

Pre-operative

* Marked degenerative spondylolisthesis (\>4mm)
* Lesions requiring surgery involving two levels
* Prior surgery at index level or adjacent level
* Prior spinal fusion surgery
* Isthmic or lytic spondylolisthesis
* Incompetent or missing posterior arch at the affected level (e.g. complete laminectomy, pars defect)
* Requires complete laminectomy at level of surgery
* Facet joints at implant level are absent or fractured
* Vertebral body compromise or acute fracture at implant level
* Body mass Index (BMI) ≥ 35
* Known allergy to titanium
* Osteoporosis: SCORE (Simple Calculated Osteoporosis Risk Estimation) will be used to screen subjects requiring DEXA. Subjects with T-score \< -2.5 will be excluded
* Paget's disease, osteomalacia, or any other metabolic bone disease
* Use of medications or any drug known to potentially interfere with bone/soft tissue healing (e.g. chronic systemic steroids)
* Planned use of additional segmental fixation (eg. facet screws, anterior/lateral plating, anchored cages)
* Use of Bone Morphogenetic Protein (BMP)\*
* Unlikely to comply with the follow-up evaluation schedule
* In the opinion of the Investigator, Subject has history of chemical substance dependency or significant psychosocial disturbance that may impact the outcome or study participation
* Active participation in a clinical trial of another drug or device
* Active systemic infection or any other health condition that would preclude surgery
* History of invasive malignancy, except if the subject has received treatment and displayed no clinical signs and symptoms for at least five years
* Pregnant or planning to become pregnant during study participation
* Involvement in active litigation related to back problems at the time of screening
* Direct involvement in the execution of this protocol
* Pre-existing conditions that could interfere with the evaluation of outcome measures (e.g. musculoskeletal, neuromuscular, etc.)

Intra-operative Exclusion

* Intra-operative visualization of a \> 4mm spondylolisthesis not previously noted radiographically

Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No